Kuznicki Law PLLC notifies investors in AEVEX Corp. (“Aevex” or the “Company”) (NYSE: AVEX) of a class action securities lawsuit. The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Aevex’s publicly traded Class A common stock between April 17, 2026 and June 4, 2026, inclusive (the “Class Period”) and/or pursuant or traceable to the registration statement and prospectus (the “IPO Offering Documents”) issued in connection with Aevex’s April 17, 2026 initial public offering (“IPO”).
According to the Complaint, Aevex and certain of its executives are charged with concealing a pre-arranged plan between Madison, which owned 100% of AEVEX’s common stock, and the Underwriter Defendants to prematurely override the commitment requiring a 180-day lock-up after the IPO to prevent Madison from selling its shares.
Specifically, the lawsuit alleges that AEVEX represented that a 180-day “lock-up” would prevent Madison from selling its Class A common stock, or from converting or exchanging its Class B shares or LLC Units into Class A common stock for public sale, until at least October 13, 2026. In truth, the Company allegedly concealed a pre-arranged plan between Madison and the Underwriter Defendants to abrogate that commitment early and clear the way for an SPO shortly after the IPO — one through which Madison would reap over $200 million and the Underwriter Defendants would share in a further $8-plus million in fees.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until October 20, 2026 to request that the court appoint them lead plaintiff.